litlas
Log inCreate account

Dan H. Moore

Active 1941–2024

148
Papers
25,111
Citations
101
h-index
145
i10-index

Citations

Citations per year for Dan H. Moore1967: 13 citations1968: 14 citations1969: 5 citations1970: 12 citations1971: 9 citations1972: 15 citations1973: 12 citations1974: 13 citations1975: 9 citations1976: 9 citations1977: 15 citations1978: 13 citations1979: 26 citations1980: 9 citations1981: 17 citations1982: 11 citations1983: 13 citations1984: 14 citations1985: 13 citations1986: 10 citations1987: 11 citations1988: 12 citations1989: 5 citations1990: 9 citations1991: 24 citations1992: 27 citations1993: 60 citations1994: 100 citations1995: 111 citations1996: 77 citations1997: 117 citations1998: 112 citations1999: 83 citations2000: 130 citations2001: 145 citations2002: 147 citations2003: 149 citations2004: 167 citations2005: 193 citations2006: 173 citations2007: 172 citations2008: 233 citations2009: 199 citations2010: 202 citations2011: 195 citations2012: 217 citations2013: 213 citations2014: 221 citations2015: 210 citations2016: 186 citations2017: 167 citations2018: 167 citations2019: 405 citations2020: 437 citations2021: 401 citations2022: 304 citations2023: 170 citations2024: 280 citations2025: 94 citations2026: 4 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,985 citing papers, 34.1% of this breakdownUnited Kingdom: 726 citing papers, 8.3% of this breakdownCanada: 429 citing papers, 4.9% of this breakdownItaly: 425 citing papers, 4.8% of this breakdownChina: 423 citing papers, 4.8% of this breakdownGermany: 409 citing papers, 4.7% of this breakdownFrance: 259 citing papers, 3% of this breakdownAustralia: 253 citing papers, 2.9% of this breakdownJapan: 248 citing papers, 2.8% of this breakdownNetherlands: 241 citing papers, 2.7% of this breakdownSpain: 212 citing papers, 2.4% of this breakdownSweden: 159 citing papers, 1.8% of this breakdown
0%34.1%Other 22.8%

Institutions

Fields

  • Medicine53.8%
  • Biochemistry, Genetics and Molecular Biology31.7%
  • Neuroscience3.2%
  • Immunology and Microbiology3.1%
  • Materials Science2%
  • Environmental Science1.5%
  • Other4.7%

Topics

  • Amyotrophic Lateral Sclerosis Research4.3%
  • Breast Cancer Treatment Studies2.5%
  • Neurogenetic and Muscular Disorders Research2.2%
  • Angiogenesis and VEGF in Cancer2%
  • Cannabis and Cannabinoid Research1.5%
  • Cancer-related Molecular Pathways1.5%
  • Other86%

Coauthors

All papers

Open in search
  1. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)

    Authors: Robert G. Miller, John D. Mitchell, Dan H. Moore - Cochrane Database of Systematic Reviews 2012 cited by 1,049

  2. Regulatory T‐lymphocytes mediate amyotrophic lateral sclerosis progression and survival

    Authors: Jenny S. Henkel, David R. Beers, Shixiang Wen, Andreana L. Rivera, Karen M. Toennis, Joan E. Appel, Weihua Zhao, Dan H. Moore, Suzanne Z. Powell, Stanley H. Appel - EMBO Molecular Medicine 2012 cited by 349

  3. Cannabidiol Enhances the Inhibitory Effects of Δ9-Tetrahydrocannabinol on Human Glioblastoma Cell Proliferation and Survival

    Authors: Jahan P. Marcu, Rigel T. Christian, Darryl Lau, Anne J. Zielinski, Maxx P. Horowitz, Jasmine Lee, Arash Pakdel, Juanita Allison, Chandani Limbad, Dan H. Moore, Garret Yount, Pierre‐Yves Desprez, Sean D. McAllister - Molecular Cancer Therapeutics 2010 cited by 167

  4. Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial

    Authors: Paul H Gordon, Dan H. Moore, Robert G. Miller, Julaine Florence, Joseph L. Verheijde, Carolyn Doorish, Joan F. Hilton, G. Mark Spitalny, Robert B. MacArthur, Hiroshi Mitsumoto, Hans E. Neville, Khrista Boylan, Tahseen Mozaffar, Jerry M. Belsh, John Ravits, Richard Bedlack, Michael C. Graves, Leo McCluskey, Richard J. Barohn, Rup Tandan - The Lancet Neurology 2007 cited by 642

  5. Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis

    Authors: Sean D. McAllister, Ryuichi Murase, Rigel T. Christian, Darryl Lau, Anne J. Zielinski, Juanita Allison, Carolina Almanza, Arash Pakdel, Jasmine Lee, Chandani Limbad, Yong Liu, Robert J. Debs, Dan H. Moore, Pierre‐Yves Desprez - Breast Cancer Research and Treatment 2010 cited by 225

  6. Synuclein-One Study: Skin Biopsy Detection of Phosphorylated α-Synuclein for Diagnosis of Synucleinopathies

    Authors: Christopher H. Gibbons, Roy Freeman, Bailey Bellaire, Charles H. Adler, Dan H. Moore, Todd Levine - Biomarkers in Medicine 2022 cited by 33

  7. Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer

    Authors: Elisabeth R. Garwood, Anjali S. Kumar, Frederick L. Baehner, Dan H. Moore, Alfred Au, Nola M. Hylton, Chris I. Flowers, Judy E. Garber, Beth‐Ann Lesnikoski, E. Shelley Hwang, O. Olopade, Elisa Port, Michael J. Campbell, Laura J. Esserman - Breast Cancer Research and Treatment 2009 cited by 217

  8. Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility

    Authors: C Hardwick, Kishalay Hoare, R.J. Owens, H-P. Hohn, Magnus Höök, Dan H. Moore, V Cripps, L Austen, DM Nance, EA Turley - The Journal of Cell Biology 1992 cited by 410

  9. The Combined Assessment of Function and Survival (CAFS): A new endpoint for ALS clinical trials

    Authors: James D. Berry, Robert G. Miller, Dan H. Moore, Merit Cudkowicz, Leonard H. van den Berg, Douglas A. Kerr, Yingwen Dong, Evan W. Ingersoll, Donald Archibald - Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2013 cited by 115

  10. Tumor Angiogenesis: A New Significant and Independent Prognostic Indicator in Early-Stage Breast Carcinoma

    Authors: Noel Weidner, J Folkman, F. Pozza, Pierantonio Bevilacqua, Elizabeth N. Allred, Dan H. Moore, S Meli, Giampietro Gasparini - JNCI Journal of the National Cancer Institute 1992 cited by 1,794

  11. Detecting frontotemporal dysfunction in ALS: Utility of the ALS Cognitive Behavioral Screen (ALS-CBS™)

    Authors: Susan Woolley, Michele K. York, Dan H. Moore, Adriana M. Strutt, Jennifer Murphy, Paul E. Schulz, Jonathan Katz - Amyotrophic Lateral Sclerosis 2010 cited by 220

  12. Phase I clinical trial of safety of L-serine for ALS patients

    Authors: Todd Levine, Robert G. Miller, Walter G. Bradley, Dan H. Moore, David Saperstein, Lynne E. Flynn, Jonathan Katz, Dallas Forshew, James S. Metcalf, Sandra Anne Banack, Paul Alan Cox - Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2016 cited by 77

  13. AM1241, a cannabinoid CB2 receptor selective compound, delays disease progression in a mouse model of amyotrophic lateral sclerosis

    Authors: Kathline Kim, Dan H. Moore, Alexandros Makriyannis, Mary E. Abood - European Journal of Pharmacology 2006 cited by 149

  14. Efficacy of Short-Course Antibiotic Regimens for Community-Acquired Pneumonia: A Meta-analysis

    Authors: Jonathan Z. Li, Lisa G. Winston, Dan H. Moore, Stephen Bent - The American Journal of Medicine 2007 cited by 177

  15. Implications of ALS focality

    Authors: John Ravits, Patrick Laurie, Yuxin Fan, Dan H. Moore - Neurology 2007 cited by 157

  16. AN ELECTROPHORETIC STUDY OF THE PROTEIN COMPONENTS IN CEREBROSPINAL FLUID AND THEIR RELATIONSHIP TO THE SERUM PROTEINS 1

    Authors: Elvin A. Kabat, Dan H. Moore, Harold Landow - Journal of Clinical Investigation 1942 cited by 461

  17. Valerian for Sleep: A Systematic Review and Meta-Analysis

    Authors: Stephen Bent, Amy Padula, Dan H. Moore, Michael Patterson, Wolf Mehling - The American Journal of Medicine 2006 cited by 385

  18. Human Placental Vascular Development: Vasculogenic and Angiogenic (Branching and Nonbranching) Transformation Is Regulated by Vascular Endothelial Growth Factor-A, Angiopoietin-1, and Angiopoietin-2

    Authors: Eli Geva, David G. Ginzinger, Charles Zaloudek, Dan H. Moore, Annette T. Byrne, Robert B. Jaffe - The Journal of Clinical Endocrinology & Metabolism 2002 cited by 255

  19. Cannabinoids selectively inhibit proliferation and induce death of cultured human glioblastoma multiforme cells

    Authors: Sean D. Mc Allister, Calvin C. Chan, Ryan J. Taft, Tri Luu, Mary E. Abood, Dan H. Moore, Ken Aldape, Garret Yount - Journal of Neuro-Oncology 2005 cited by 102

  20. Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.

    Authors: John W. Park, Keelung Hong, Dmitri B. Kirpotin, Gail Colbern, Refaat Shalaby, José Baselga, Yvonne Shao, Ulrik B. Nielsen, James D. Marks, Dan H. Moore, Demetrios Papahadjopoulos, Christopher C. Benz - 2002 cited by 648

  21. Proliferating macrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcome

    Authors: Michael J. Campbell, Nathan Tonlaar, Elisabeth R. Garwood, Dezheng Huo, Dan H. Moore, Andrey Khramtsov, A. der Au, Frederick L. Baehner, Yinghua Chen, David Malaka, Amy Lin, Oyinlolu Olorunsogo Adeyanju, Shihong Li, Can Gong, Michael S. McGrath, Olufunmilayo I. Olopade, Laura J. Esserman - Breast Cancer Research and Treatment 2010 cited by 263

  22. A multigene predictor of metastatic outcome in early stage hormone receptor-negative and triple-negative breast cancer

    Authors: Christina Yau, Laura J. Esserman, Dan H. Moore, Fred Waldman, John J. Sninsky, Christopher C. Benz - Breast Cancer Research 2010 cited by 214

  23. Id-1 Is a Key Transcriptional Regulator of Glioblastoma Aggressiveness and a Novel Therapeutic Target

    Authors: Liliana Soroceanu, Ryuichi Murase, Chandani Limbad, Eric A. Singer, Juanita Allison, Isabel Adrados, Rumi Kawamura, Arash Pakdel, Yayoi Fukuyo, Daniel Nguyen, Sabeena Khan, Robert Arauz, Garret Yount, Dan H. Moore, Pierre‐Yves Desprez, Sean D. McAllister - Cancer Research 2012 cited by 154

  24. Long-term Prognostic Role of Functional Limitations Among Women With Breast Cancer

    Authors: Dejana Braithwaite, William A. Satariano, Barbara Sternfeld, Robert A. Hiatt, Patricia A. Ganz, Karla Kerlikowske, Dan H. Moore, Martha L. Slattery, Martin C. Tammemägi, A Castillo, ME Melisko, Laura Esserman, Erin Weltzien, Bette J. Caan - JNCI Journal of the National Cancer Institute 2010 cited by 147